SCHEMBL17847506

SCHEMBL17847506

O=C(O)CN1CCC(Nc2cc(=O)oc3ccccc23)CC1

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 8/20 0.67
KDM4E B2RXH2 1/20 0.62
LMNA P02545 1/20 0.62
MAOB P27338 1/20 0.47
KCNH2 Q12809 1/20 0.46
CNR1 P21554 1/20 0.46
RECQL P46063 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALDH1A1 P00352 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17865094 0.85 MCHR1 (0.61) MCHR1KDM4ELMNAKCNH2HPGD
SCHEMBL17847541 0.85 LMNA (0.67) MCHR1KDM4ELMNAMAOBRECQL
SCHEMBL25669374 0.83 MCHR1 (0.55) MCHR1KDM4ELMNAMAOBKCNH2
SCHEMBL23379176 0.83 MCHR1 (0.55) MCHR1KDM4ELMNAKCNH2ALDH1A1
SCHEMBL17845025 0.82 MCHR1 (0.64) MCHR1KDM4ELMNAKCNH2RECQL
SCHEMBL6190122 0.81 MCHR1 (0.64) MCHR1KDM4ELMNAKCNH2HPGD
SCHEMBL13440560 0.81 LMNA (0.86) MCHR1KDM4ELMNARECQLHPGD
SCHEMBL17861411 0.81 MCHR1 (0.63) MCHR1KDM4ELMNAKCNH2
SCHEMBL17861413 0.81 MCHR1 (0.63) MCHR1KDM4ELMNAKCNH2RECQL
SCHEMBL23360021 0.81 MCHR1 (0.53) MCHR1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10369130-B2 Antibacterial compounds AZIEN DE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) 2019-08-06 US disclosed
US-10369130-B2 Antibacterial compounds AZIEN DE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) 2019-08-06 US disclosed
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-28 US disclosed
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-28 US disclosed
EP-3233826-A1 NEW ANTIBACTERIAL COMPOUNDS Aziende Chimiche Riunite Angelini Francesco A.C.R. (IT) 2017-10-25 EP disclosed
WO-2016096631-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2016-06-23 WO disclosed
WO-2016096631-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10369130-B2 Antibacterial compounds MRPL21, CLPP, NRDC MCHR1 4595/4885KDM4E 4034/4885LMNA 3985/4885
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS MRPL21, CLPP, NRDC MCHR1 4595/4885KDM4E 4034/4885LMNA 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.